| 
			
			
			
			
			
			
			
			
			
			
			
		 | 
		 | 
		
 
 
	
	
		  | 
	 
	
	
		Native Protein A Pre-packed column
  - resin : nProtein A Sepharose 4 FF, GE Healthcare
  - packing : 10ml, 1set (cat.# DSP-10-07n)
  - Accessories included : 1/16" male union, 1ea.                                   6mm male union, 1ea.                                   2¥Õx0.5tx1m PTFE tubing(with 6mm union), 1set                                   Plug valve, 1ea.; º¸³Ê½ºÀ̺¥Æ® ----------------------------------------------------------------------------------------------------------
  
BPXTM Ds10-nProtein A :  Cat.#DSP-10-07n 
BPXTM Ds10-nProtein A are prepacked native Protein A coupled to Sepharose 4 Fast Flow for the purification of monoclonal and polyclonal antibodies at both laboratory and process scale. 
nProtein A Sepharose 4 Fast Flow is native protein A coupled to the well established Sepharose 4 Fast Flow base matrix. The native protein A ligand is produced by fermenting a selected strain of Staphylococcus aureus. The purified protein is coupled to the cross-linked 4% agarose base matrix by the cyanogen bromide technique, giving a highly stable medium with minimal non-specific adsorption. nProtein A Sepharose 4 Fast Flow is manufactured without using animal-derived components. 
nProtein A Sepharose 4 Fast Flow has nearly twice the total IgG binding capacity of Protein A Sepharose CL-4B, and is suitable for recovery and purification of monoclonal antibodies from cell culture at both laboratory and process scale. nProtein A Sepharose 4 Fast Flow was developed and tested in co-operation with leading manufacturers of purified monoclonal antibody products, and is used in routine commercial production. 
- Quick, convenient preparative purification of monoclonal antibodies. 
 - Free from animal-derived components. 
 - Well-established protein A-based medium used in many approved MAb processes. 
 - Recombinant protein A exhibits similar Fc region specificity to that of native protein A but shows enhanced binding capacity and fewer regulatory concerns due to the total absence of mammalian culture in the ligand production and purification. 
 - High flow rates and high capacities 
 - Easy & predictable scale-up 
 - Compatible design for use with syringes, single laboratory pump, or chromatography system
  
| 
 Column  | 
 BPXTM DSC-102  |  
| 
 Column Volume  
Bed Volume  | 
 10 ml  
10 ml (15¥Õ x 57 mm)  |  
| 
 Column Dimensions   | 
 17¥Õ x 102 mm   |  
| 
 Flow rate   | 
 1 ml/min - 6 ml/min  |  
| 
 Flow Velocity   | 
 > 600 cm/hr   |  
| 
 Pressure Max.   | 
 1.5 bar [0.15 MPa] (22 psi)   |  
| 
 Material  | 
 Polypropylene (PP)  |  
| 
 Bed Support & Filter  | 
 Polypropylene (PP) & STS316L Sintered wire mesh filter  |  
 | 
 |   
 
| 
  Media
  | 
  GE Healthcare Cat.# 17-5280-01 / nProtein A 4 FF
  |  
| 
 Ligand  | 
 native Staphylococcal Protein A (S. aureus)  |  
| 
 Average Particle Size  | 
 90 µm  |  
| 
 Type  | 
 native Protein A Affinity  |  
| 
 Matrix  | 
 4% cross-linked agarose  |  
| 
 Ligand conc.  | 
 6 mg Protein A / ml medium  |  
| 
 Ligand coupling method  | 
 Cyanogen bromide activation  |  
| 
 Binding Capacity  | 
 > 30 mg/ml hIgG  |  
| 
 pH stability   | 
 Working, 3-9 
Cleaning, 2-10  |  
| 
 Flow Specification  | 
 < 300 cm/h, 100 kPa, BPX 50/25 column, bed height 15 cm  |  
| 
 Exclusion Limit [Mr] [Globular Proteins]  | 
 4 x 106  |  
| 
 Storage Conditions  | 
 4 to 30¡ÆC, 20% Ethanol  |  
| 
 Estimated Shelflife  | 
 3 years from Manufacture Date  |  
| 
 Chemical Stability  | 
 Stable to all commonly used aqueous buffers and 20% ethanol1)  |  
| 
 l  CIP : 0.1 N NaOH cleaning is not applicable. 0.1M Glycine(pH3.0) is generally safe for CIP.  |    | 
	 
 
 
			
	
	
		  | 
	 
	
	
		 | 
	 
 
 
 
 
  
		 |